FDA extends shelf life of Johnson & Johnson vax vaccine
11-June-2021

Johnson & Johnson said on Thursday the US Food and Drug Administration has extended the shelf life of its single-shot Covid-19 vaccine from 3 months to 4.5 months, as millions of unused doses nationwide are set to expire this month.
The decision is based on data from ongoing stability assessment studies, which have demonstrated that the vaccine is stable at 4.5 months when refrigerated at temperatures of 36 to 46 degrees Fahrenheit, or 2 to 8 degrees Celsius, according to the drugmaker, Xinhua reported.
"Evidence from our Phase 3 ENSEMBLE study demonstrates the efficacy of our single-shot COVID-19 vaccine, including against viral variants that are highly prevalent. Regardless of race and ethnicity, age, geographic location and comorbidities, these results remain consistent," the company said in a statement.
Of the 21.4 million Johnson & Johnson doses distributed nationwide as of Wednesday, only 11.2 million doses have been administered, according to data of the US Centers for Disease Control and Prevention. It means half of the doses produced for the United States sitting unused.-IANS
Gen Z Protests Push Nepal to Restore Social Media Access After Youth-Led Unrest
Trump Softens Tone on India: “I’ll Always Be Friends With Modi” as Trade Row Deepens
AIADMK Rift Deepens: K.A. Sengottaiyan Demands Return of Expelled Leaders, Ultimatum to EPS
Kerala Custodial Torture Row: Man Alleges Police Tried to Pull Out Teeth With Pliers
Pallavi Joshi Pens Open Letter to President Murmu Over The Bengal Files Release in West Bengal